Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated …

Nov 20, 2025 · Wondering if Illumina is attractively priced or if there is still more room to fall? You are not alone, as many investors are watching its valuation story unfold in real time. Despite a ...

We are Illumina We are a global genomics and human health leader innovating the future of precision health. We develop DNA sequencing and array-based life sciences technologies to …

Dec 18, 2023 · Illumina’s decision to unwind its acquisition of Grail ensures the market for cancer detection tests remains competitive and delivers a choice of high-quality tests for patients and …

Illumina Ventures is the leader in genomics and precision health investing. We are building the ecosystem and translating investment into innovation as we accelerate the impact on human …

1 day ago · JPMorgan Chase & Co. grew its position in Illumina, Inc. (NASDAQ:ILMN - Free Report) by 7.7% in the second quarter, according to its most recent 13F filing with the …

Illumina offers a broad range of sequencing and microarray products for diverse genomic analysis applications.

Illumina Consulting Group, Inc is a Software Development company located in Chantilly, Virginia with 8 employees. Find top employees, contact details and business statistics at RocketReach.

Nov 19, 2025 · A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, …